Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Polydefkis

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Scientific Reports|May 25, 2021
Ethoxyquin is neuroprotective and partially prevents somatic and autonomic neuropathy in db/db mouse model of type 2 diabetesYing Liu, Yuan Sun, Osefame Ewaleifoh, et al.
Journal of Translational Medicine|March 11, 2011
Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studiesCamilo Rojas, Marigo Stathis, Michael Polydefkis, et al.
Brain : a Journal of Neurology|September 28, 2007
Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsiesGigi J Ebenezer, Justin C McArthur, Diane Thomas, et al.
Expert Opinion on Pharmacotherapy|November 30, 2018
An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathyViolaine Planté-Bordeneuve, Hollis Lin, Jared Gollob, et al.
Arthritis Care & Research|December 15, 2015
Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in SclerodermaJulie J Paik, Andrew L Mammen, Fredrick M Wigley, et al.
The Lancet. Neurology|October 20, 2023
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatmentDavid Adams, Yoshiki Sekijima, Isabel Conceição, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 20, 2023
Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension studySimina Ticau, Emre Aldinc, Michael Polydefkis, et al.
Scientific Reports|January 28, 2017
Sensory and autonomic function and structure in footpads of a diabetic mouse modelYing Liu, Blessan Sebastian, Ben Liu, et al.
Pain|October 25, 2016
Peripheral neuropathic changes in pachyonychia congenitaBaohan Pan, Kelly Byrnes, Mary Schwartz, et al.
Neurology|March 20, 2023
Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin AmyloidosisSerena Zampino, Farooq H Sheikh, Joban Vaishnav, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Scientific Reports|May 25, 2021
Ethoxyquin is neuroprotective and partially prevents somatic and autonomic neuropathy in db/db mouse model of type 2 diabetesYing Liu, Yuan Sun, Osefame Ewaleifoh, et al.
Journal of Translational Medicine|March 11, 2011
Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studiesCamilo Rojas, Marigo Stathis, Michael Polydefkis, et al.
Brain : a Journal of Neurology|September 28, 2007
Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsiesGigi J Ebenezer, Justin C McArthur, Diane Thomas, et al.
Expert Opinion on Pharmacotherapy|November 30, 2018
An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathyViolaine Planté-Bordeneuve, Hollis Lin, Jared Gollob, et al.
Arthritis Care & Research|December 15, 2015
Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in SclerodermaJulie J Paik, Andrew L Mammen, Fredrick M Wigley, et al.
The Lancet. Neurology|October 20, 2023
Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatmentDavid Adams, Yoshiki Sekijima, Isabel Conceição, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 20, 2023
Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension studySimina Ticau, Emre Aldinc, Michael Polydefkis, et al.
Scientific Reports|January 28, 2017
Sensory and autonomic function and structure in footpads of a diabetic mouse modelYing Liu, Blessan Sebastian, Ben Liu, et al.
Pain|October 25, 2016
Peripheral neuropathic changes in pachyonychia congenitaBaohan Pan, Kelly Byrnes, Mary Schwartz, et al.
Neurology|March 20, 2023
Phenotypes Associated With the Val122Ile, Leu58His, and Late-Onset Val30Met Variants in Patients With Hereditary Transthyretin AmyloidosisSerena Zampino, Farooq H Sheikh, Joban Vaishnav, et al.
Pageof 9